Chronic Inhibition of Mammalian Target of Rapamycin Signaling Downregulates Insulin Receptor Substrates 1 and 2 and AKT Activation: A Crossroad between Cancer and Diabetes? : Journal of the American Society of Nephrology

Journal Logo

Clinical Nephrology

Chronic Inhibition of Mammalian Target of Rapamycin Signaling Downregulates Insulin Receptor Substrates 1 and 2 and AKT Activation

A Crossroad between Cancer and Diabetes?

Di Paolo, Salvatore; Teutonico, Annalisa; Leogrande, Domenica; Capobianco, Carmen; Schena, Paolo F.

Author Information
Journal of the American Society of Nephrology 17(8):p 2236-2244, August 2006. | DOI: 10.1681/ASN.2006030196

Abstract

Copyright © 2006 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid